A panel of 19 cell lines, derived from different tumor types, with a range of KRAS WT CN amplifications was selected to further explore the antiproliferative effect of BI-2493 and BI-2865 (Fig. 3A; ref. 10). This evidence concerns the gene KRAS and neoplasm.